Real-world (rw) outcomes to chemoimmunotherapy and biomarker analysis in extensive-stage small cell lung cancer (ES SCLC)

被引：0
|
作者：
Panagiotou, E. [1 ]
Livanou, M. E. [1 ]
Montgomery, A. [2 ]
Mastrogeorgiou, M. [1 ]
Moeckel, C. [2 ]
Syrigos, N. [1 ]
Mouratidis, I. [2 ]
Charpidou, A. [1 ]
Georgakopoulos-Soares, I. [2 ]
Vathiotis, I. [1 ]
机构：
[1] Sotiria Thorac Dis Hosp Athens, Med Oncol, Athens, Greece
[2] Penn State Coll Med, Biochem & Mol Biol, Hershey, PA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1238
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2007P
引用
收藏
页码：S1069 / S1069
页数：1
相关论文
共 50 条
  • [21] Brazilian real-world data of immunotherapy (IO) in extensive disease small cell lung cancer (ES-SCLC)
    Duarte, F. A.
    Dienstmann, R.
    Diniz, P.
    Costa e Silva, M.
    Veloso, G. G. Viana
    Arcanjo, G.
    Paes, R.
    Montella, T.
    Cuba, H.
    Macuzo, E.
    Ferrari, B. L.
    Ferreira, C. G. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1069 - S1070
  • [22] The role of thoracic radiotherapy (TRT) in the era of chemoimmunotherapy for extensive stage small cell lung cancer (ES-SCLC)
    Turner, Cassie L.
    Prasetio, Tito E.
    O'Berine, Shannon
    Anderson, Georgina
    Hughes, Brett G. M.
    Vignarajah, Dinesh
    Castelli, Joanne
    Lwin, Zarnie
    Houston, Kathleen
    Chan, Bryan A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 167 - 167
  • [23] Prognostic implications of neutrophil-to-lymphocyte ratio in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy: A multicenter, real-world study
    Bi, Huanhuan
    Ren, Dunqiang
    Xiao, Yuting
    Zhou, Yinxue
    Yi, Bingqian
    Han, Weizhong
    Shao, Yanmei
    Wang, Jingluan
    Zhang, Chunling
    Wang, Hongmei
    THORACIC CANCER, 2024, 15 (07) : 559 - 569
  • [24] Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC)
    Cramer-van der Welle, Christine
    Schramel, Franz M. N. H.
    Van Leeuwen, Arvid S.
    Klungel, Olaf H.
    Groen, Harry J. M.
    Van de Garde, Ewoudt M. W.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [25] Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study
    Takeda, Takayuki
    Yamada, Tadaaki
    Kunimatsu, Yusuke
    Tanimura, Keiko
    Morimoto, Kenji
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Okada, Asuka
    Horiuchi, Shigeto
    Hibino, Makoto
    Uryu, Kiyoaki
    Honda, Ryoichi
    Yamanaka, Yuta
    Yoshioka, Hiroshige
    Kurata, Takayasu
    Takayama, Koichi
    CANCERS, 2023, 15 (05)
  • [26] A Real-World Study of the Efficacy of Immune-Checkpoint Inhibitors for Extensive-Stage Small Cell Lung Cancer
    Liu, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E411 - E411
  • [27] Real-world comparison of the efficacy and safety of atezolizumab versus durvalumab in extensive-stage small cell lung cancer
    Vince, Megan
    Naqvi, Syeda Mahrukh Hussnain
    Pellini, Bruna
    Verbosky, Michael
    Melzer, Dan
    LUNG CANCER, 2024, 198
  • [28] The Drug Induced Interstitial Lung Disease in Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer
    Takamiya, R.
    Fukuda, K.
    Katsurada, N.
    Kawa, Y.
    Satouchi, M.
    Kaneshiro, K.
    Matsumoto, M.
    Hatakeyama, Y.
    Dokuni, R.
    Matsumura, K.
    Katsurada, M.
    Nakata, K.
    Yoshimura, S.
    Tachihara, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S553 - S553
  • [29] Real-world data on immunotherapy combined with chemotherapy in elderly patients with extensive-stage small cell lung cancer
    Zhao, Ke
    Lu, Shuangqing
    Niu, Jiling
    Zhu, Hui
    Tian, Yaru
    Yu, Jinming
    BMC CANCER, 2025, 25 (01)
  • [30] Treatment patterns in extensive-stage small cell lung cancer: A retrospective real-world data study.
    Ganti, Apar Kishor
    Katranji, Kenan
    Seal, Brian S.
    Brannman, Lance
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
12345